CT定量与机器学习模型评估COVID-19患者疾病严重程度及预后
本研究回顾性纳入99例核酸确诊的COVID-19住院患者,用两个U-Net模型分割肺与病灶并计算肺体积、病灶体积、非病灶肺体积及占比等CT定量指标,结合直方图纹理构建随机森林模型评估疾病严重程度并预测ICU入住、氧疗及住院时长等结局。混合模型分类中度与(重度+危重)、重度与危重的AUC分别为0.927和0.929,预测ICU治疗与预后的AUC分别为0.945和0.960。
要点
- 非病灶肺体积占比在轻度、重度、危重组分别为92.18±9.89%、82.94±16.49%、66.19±24.15%,两两比较P<0.05。
- 混合随机森林模型分类中度与(重度+危重)AUC 0.927、重度与危重AUC 0.929,显著高于影像组学模型或临床模型(P<0.05)。
- 预测ICU治疗AUC 0.945,预测部分恢复与恢复迁延AUC 0.960。
核心结论
- CT定量与机器学习模型在评估COVID-19疾病严重程度和预测临床结局方面显示出辅助决策的较大潜力。
研究设计与样本
- 回顾性研究,纳入2020年1月19日至2020年2月19日住院、经RT-PCR核酸检测阳性的COVID-19患者99例。
- 所有患者入院时接受动脉血气分析、血常规、胸部CT和体格检查,并收集疾病严重程度、临床治疗及临床结局等随访资料。
- 采用两个U-Net模型在CT图像上分割肺与COVID-19病灶,量化肺体积、病灶体积、非病灶肺体积及非病灶肺体积占比,并分别计算病灶体积与非病灶肺体积的20个直方图纹理。
- 构建随机森林分类与回归模型,评估疾病严重程度(中度、重度、危重),预测ICU入住需求及时长、氧疗时长、住院时长、痰核酸阳性时长及患者预后。
关键影像表现/征象
- 按临床分期分为中度25例、重度47例、危重27例三组。
- 三组入住ICU例数分别为中度1例(1/25)、重度6例(6/47)、危重25例(25/27)。
- 三组ICU停留中位数分别为0、0、12天,氧疗时长中位数分别为10、15、28天,住院时长中位数分别为12、16、28天,痰核酸阳性时长中位数分别为8、9、13天。
- 临床结局为完全康复3例、部分恢复伴残留肺损伤80例、恢复迁延15例、死亡1例。
诊断标准与关键数值
- 非病灶肺体积占比在三组分别为92.18±9.89%、82.94±16.49%、66.19±24.15%,两两比较P<0.05。
- 混合随机森林分类器分类中度与(重度+危重)AUC为0.927,分类重度与危重AUC为0.929,均显著高于影像组学模型或临床模型(P<0.05)。
- 随机森林回归器预测住院时长的均方根误差为0.88周(均值2.60±1.01周),预测氧疗时长0.92周(均值2.44±1.08周),预测痰核酸阳性时长0.90周(均值1.59±0.98周),预测ICU停留0.69周(均值1.32±0.67周)。
- 预测ICU治疗AUC为0.945,预测预后(部分恢复与恢复迁延)AUC为0.960。
临床应用与阅片要点
- 基于U-Net分割的CT定量指标(肺体积、病灶体积、非病灶肺体积占比)可用于COVID-19疾病严重程度的分层评估。
- 随机森林混合模型结合CT定量与临床指标,有助于预测ICU入住需求、氧疗时长及住院时长等临床结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study was to investigate the CT quantification of COVID-19 pneumonia and its impacts on the assessment of disease severity and the prediction of clinical outcomes in the management of COVID-19 patients.
MATERIALS METHODS: Ninety-nine COVID-19 patients who were confirmed by positive nucleic acid test (NAT) of RT-PCR and hospitalized from January 19, 2020 to February 19, 2020 were collected for this retrospective study. All patients underwent arterial blood gas test, routine blood test, chest CT examination, and physical examination on admission. In addition, follow-up clinical data including the disease severity, clinical treatment, and clinical outcomes were collected for each patient. Lung volume, lesion volume, nonlesion lung volume (NLLV) (lung volume - lesion volume), and fraction of nonlesion lung volume (%NLLV) (nonlesion lung volume / lung volume) were quantified in CT images by using two U-Net models trained for segmentation of lung and COVID-19 lesions in CT images. Furthermore, we calculated 20 histogram textures for lesions volume and NLLV, respectively. To investigate the validity of CT quantification in the management of COVID-19, we built random forest (RF) models for the purpose of classification and regression to assess the disease severity (Moderate, Severe, and Critical) and to predict the need and length of ICU stay, the duration of oxygen inhalation, hospitalization, sputum NAT-positive, and patient prognosis. The performance of RF classifiers was evaluated using the area under the receiver operating characteristic curves (AUC) and that of RF regressors using the root-mean-square error.
RESULTS: Patients were classified into three groups of disease severity: moderate (n = 25), severe (n = 47) and critical (n = 27), according to the clinical staging. Of which, a total of 32 patients, 1 (1/25) moderate, 6 (6/47) severe, and 25 critical (25/27), respectively, were admitted to ICU. The median values of ICU stay were 0, 0, and 12 days, the duration of oxygen inhalation 10, 15, and 28 days, the hospitalization 12, 16, and 28 days, and the sputum NAT-positive 8, 9, and 13 days, in three severity groups, respectively. The clinical outcomes were complete recovery (n = 3), partial recovery with residual pulmonary damage (n = 80), prolonged recovery (n = 15), and death (n = 1). The %NLLV in three severity groups were 92.18 ± 9.89%, 82.94 ± 16.49%, and 66.19 ± 24.15% with p value <0.05 among each two groups. The AUCs of RF classifiers using hybrid models were 0.927 and 0.929 in classification of moderate vs (severe + critical), and severe vs critical, respectively, which were significantly higher than either radiomics models or clinical models (p < 0.05). The root-mean-square errors of RF regressors were 0.88 weeks for prediction of duration of hospitalization (mean: 2.60 ± 1.01 weeks), 0.92 weeks for duration of oxygen inhalation (mean: 2.44 ± 1.08 weeks), 0.90 weeks for duration of sputum NAT-positive (mean: 1.59 ± 0.98 weeks), and 0.69 weeks for stay of ICU (mean: 1.32 ± 0.67 weeks), respectively. The AUCs for prediction of ICU treatment and prognosis (partial recovery vs prolonged recovery) were 0.945 and 0.960, respectively.
CONCLUSION: CT quantification and machine-learning models show great potentials for assisting decision-making in the management of COVID-19 patients by assessing disease severity and predicting clinical outcomes.
引用
- Cai W, Liu T, Xue X, et al. CT Quantification and Machine-learning Models for Assessment of Disease Severity and Prognosis of COVID-19 Patients. Acad Radiol. 2020. PMID: 33046370. doi:10.1016/j.acra.2020.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。